搜索筛选:
搜索耗时0.0829秒,为你在为你在102,285,761篇论文里面共找到 7 篇相符的论文内容
发布年度:
The oral c-Met inhibitor MSC2156119J as monotherapy vs sorafenib in Asian patients with Met-positive
[会议论文] 作者：Shukui Qin,Ann-Lii Cheng,Ho Yeong Lim,Lianzhe Xu,Cindy Li,Friedhelm Bladt,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
...
The oral c-Met inhibitor MSC2156119J as monotherapy vs sorafenib in Asian patients with Met-positive
[会议论文] 作者：Shukui Qin,Ann-Lii Cheng,Ho Yeong Lim,Lianzhe Xu,Cindy Li,Friedhelm Bladt,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
Objective: Advanced hepatocellular carcinoma (HCC) is a leading cause of cancer death, particularly in Asia where ～80％ of HCC incidences occur.Although sorafenib is the recommended treatment, it is no...
[会议论文] 作者：Shukui Qin,Ho yeong Lim,Baek-yeol Ryoo,Cindy Li,Huiling Xiong,Christian Ihling,Ann-lii Cheng,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Objective: The overall prognosis of advanced hepatocellular cancer (HCC) remains poor, with c-Met abnormalities associated with a particularly poor prognosis.The highly selective c-Met inhibitor tepot...
First-line tepotinib (MSC2156119J), an oral c-Met inhibitor, versus sorafenib in Asian patients with
[会议论文] 作者：Shukui Qin,Ho yeong Lim,Baek-yeol Ryoo,Cindy Li,Huiling Xiong,Andreas Johne,Ann-lii Cheng,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Background: HCC, a poor-prognosis disease for which the only approved drug is sorafenib, has a high unmet need.Factors associated with tumor aggressiveness in advanced HCC include c-Met amplification/...
[会议论文] 作者：盛锡楠,郭军,金杰,黄奕然,王金万,Ho Yeong Lim,Hirotsugu Uemura,Sun Young Rha,吴锡金,Robert John Motzer,
来源：第十六届全国临床肿瘤学大会暨2013年CSCO学术年会 年份：2013
...
[会议论文] 作者：盛锡楠,金杰,黄奕然,王金万,Ho Yeong Lim,Hirotsugu Uemura,Sun Young Rha,吴锡金,Robert John Motzer,郭军,
来源：第十六届全国临床肿瘤学大会暨2013年CSCO学术年会 年份：2013
目的:帕唑帕尼与舒尼替尼为治疗晚期肾癌的多靶点抗血管生成抑制剂,基于帕唑帕尼与舒尼替尼对照用于晚期肾癌一线治疗的Ⅲ期随机对照临床试验进行亚组分析,观察帕唑帕尼与舒尼替尼一线治疗晚期肾癌患者亚洲人群与欧美人群的疗效与安全性差异.......
[期刊论文] 作者：Suee Lee,Sung-Hyun Kim,Hyuk-Chan Kwon,Gyeong-Won Lee,Jung Hun Kang,In Gyu Hwang,Joung-Soon Jang,Ho Yeong Lim,
来源：World Journal of Gastroenterology 年份：2009
AIM: To identify the clinical features and outcomes of infrequently reported leptomeningeal carcinomatosis (LMC) of gastric cancer.METHODS: We analyzed 54 cases...
相关搜索：
